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The defective in organelle trafficking/intracellular multiplication (Dot/Icm) Type IVb
secretion system (T4SS) is the essential virulence factor for the intracellular life style
and pathogenicity of Legionella species. Screens demonstrated that an individual
L. pneumophila strain can use the Dot/Icm T4SS to translocate an unprecedented
number of more than 300 proteins into host cells, where these, so called Icm/
Dot-translocated substrates (IDTS) or effectors, manipulate host cell functions to the
benefit of the bacteria. Bioinformatic analysis of the pan-genus genome predicts at least
608 orthologous groups of putative effectors. Deciphering the function of these effectors
is key to understanding Legionella pathogenesis; however, the analysis is challenging.
Substantial functional redundancy renders classical, phenotypic screening of single gene
deletion mutants mostly ineffective. Here, I review experimental approaches that were
successfully used to identify, validate and functionally characterize T4SS effectors and
highlight new methods, which promise to facilitate unlocking the secrets of Legionella’s
extraordinary weapons arsenal.
Keywords: Legionella, Type IVb secretion system, Dot/Icm, effectors, toolbox, host targets, infection models,
functional genomics
INTRODUCTION
Legionella pneumophila was recognized as human pathogen in 1976 after a devastating outbreak
of pneumonia, termed Legionnaires’ disease, at an American Legion convention (Fraser et al.,
1977; McDade et al., 1977). Investigations into the epidemiological and pathological mechanisms
soon established that L. pneumophila is a ubiquitous, facultative intracellular pathogen of protozoa
(Rowbotham, 1980), which, after inhalation, can also thrive in human alveolar macrophages.
Key to exploiting phagocytic hosts is its ability to evade phago-lysosomal degradation (Horwitz,
1983a). Instead the bacteria create the Legionella containing vacuole (LCV) (Horwitz, 1983b),
which shelters them from intracellular defenses and intercepts nutrients, supporting replication.
The defective in organelle trafficking/intracellular multiplication (Dot/Icm) Type IVb secretion
system (T4SS) is critical for LCV biogenesis and intracellular replication (Berger and Isberg, 1993;
Segal et al., 1998). It is located at the bacterial poles and, upon membrane contact, translocates
proteins into host cells (Charpentier et al., 2009; Jeong et al., 2017), which manipulate cellular
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processes and are therefore called effectors. Although for many
Icm/Dot-translocated substrates (IDTS) an actual effect on the
host awaits demonstration, they will here collectively be referred
to as effectors.
Facilitated by the genome sequences of prototype
L. pneumophila strains (Cazalet et al., 2004; Chien et al.,
2004) screens for T4SS substrates established that each strain
translocates more than 300 proteins (Nagai et al., 2002; Luo
and Isberg, 2004; De Felipe et al., 2005, 2008; Kubori et al.,
2008; Burstein et al., 2009; Huang et al., 2011; Zhu et al., 2011;
Lifshitz et al., 2013). Comparative genomics of an increasing
number of L. pneumophila isolates and more than 38 Legionella
spp. showed that, while sharing the Dot/Icm T4SS, extensive
diversity in the effector arsenals exists (Schroeder et al., 2010;
Gomez-Valero et al., 2014; Burstein et al., 2016). Only 7 proteins
of an estimated 608 orthologous groups of effectors across the
genus are conserved in all species (Burstein et al., 2016).
Despite advances in our understanding about some effectors
(Finsel and Hilbi, 2015; So et al., 2015; Qiu and Luo, 2017),
we still lack knowledge about the functions of the majority.
Deciphering their functions is challenging, as effectors are a
heterogeneous group with limited homology to characterized
proteins. This mini-review summarizes methods that were
employed to characterize Dot/Icm T4SS effectors and highlights
additional methods that could help uncovering the weapons
which Legionella spp. hold in their arsenals.
CHARACTERISTICS OF DOT/ICM T4SS
EFFECTORS
Work over the past 15 years revealed several characteristics
of effectors. A translocation signal, which directs them to the
T4SS, is commonly found in the C-terminus (Nagai et al.,
2005). It consists of a pattern of 20–35 amino acids with
specific biophysical properties, e.g., small polar and/or charged
residues, and can include a so called E-Block motif encompassing
several glutamic acid residues (Nagai et al., 2005; Kubori et al.,
2008; Burstein et al., 2009; Huang et al., 2011; Lifshitz et al.,
2013). Some effectors comprise an additional internal export
signal (Cambronne and Roy, 2007; Jeong et al., 2015). Many
effectors are large (>100 kDa), with modular architecture
(Figure 1A), consisting of different functional domains, e.g.,
localization, target binding, and enzymatic activity domains.
Most prominent feature, which facilitated the discovery of the
first effector RalF, is the occurrence of domains with striking
homology to eukaryotic proteins (Nagai et al., 2002; Cazalet
et al., 2004; De Felipe et al., 2005; Gomez-Valero et al.,
2011).
Integration of these characteristics and parameters, such
as regulatory motifs, in machine-learning approaches enabled
prediction algorithms. Several programs are available (Meyer
et al., 2013; Zou et al., 2013; An et al., 2016). Dot/Icm effector-
focused algorithms were applied to 38 Legionella spp., revealing
not only 608 orthologous groups of effectors, but also 99
frequently-occurring domains, which facilitate the identification
of new effectors (Burstein et al., 2009, 2016; Lifshitz et al., 2013).
PROBING TRANSLOCATION AND
LOCALIZATION
Several assays for the validation of T4SS-mediated transport exist
(Figure 1B). The visualization of endogenous effectors in host
cells using antibodies and immunofluorescence (IF) or electron
microscopy (EM) is the gold standard to infer physiologically
accurate information (Figure 1B.1) and was achieved for a few
effectors, e.g., SdeA, LidA, RidL, SidC, SidM, RalF, (Nagai et al.,
2002; Luo and Isberg, 2004; Bardill et al., 2005; Machner and
Isberg, 2006; Finsel et al., 2013). An antibody against SidC was
used to visualize the reconstitution of translocation of a SidC
variant lacking its translocation signal by fusion to putative
effectors (Vanrheenen et al., 2006; Huang et al., 2011).
Alternatively, effectors were detected in host cell extracts by
immunoblot (Vanrheenen et al., 2006; Lin et al., 2015), which
in combination with fractionation steps to isolate organelles or
LCVs, also informed about their subcellular localization (Ivanov
et al., 2010; Hoffmann et al., 2014a; Lin et al., 2015).
As many effectors seem to be of low abundancy, several
assays employ overexpression and exploit that the T4SS tolerates
reporter domains fused to the N-terminus of effectors, if these
do not fold rapidly into rigid structures (Amyot et al., 2013).
One or multiple epitope tags [e.g., M45 (Weber et al., 2006),
4xHemagglutinin (HA) (Dolezal et al., 2012), 13xMyc (Viner
et al., 2012) or 3xFlag (Isaac et al., 2015)] were employed to detect
translocated effectors.
An early screen using an enzymatic reporter domain
measured restoration of an antibiotic resistance gene by the
Cre/loxP recombinase after T4SS-mediated translocation of Cre-
effector fusions from a Legionella donor into bacterial recipients
(Figure 1B.2) (Luo and Isberg, 2004). However, the β-lactamase
TEM-1 and the calmodulin-dependent adenylate-cyclase domain
of Bordetella pertussis toxin Cya are the most frequently used
enzymatic reporters (Figures 1B.3, 4), providing high sensitivity
by enzymatic signal amplification (TEM1: cleavage of a β-lactam
fluorescence resonance energy transfer (FRET) sensor; Cya;
generation of cyclic AMP) (Chen, 2004; Nagai et al., 2005; De
Felipe et al., 2008).
Despite localization of several effectors by IF, SidC is the only
imaged by super-resolution microscopy (Naujoks et al., 2016)
and no live imaging data tracking Legionella effectors during
infection exists. Lack of fluorescent protein tags compatible
with T4SS-mediated translocation might account for this.
Split fluorescent proteins, used for Salmonella T3SS effectors
(Figure 1B.5) (Van Engelenburg and Palmer, 2010) and new
enzyme-tags (Figure 1B.6) (Halo-, Snap and Clip-tags), which
self-label with fluorophores that are suitable for live-, super-
resolution- and electron-microscopy (Bottanelli et al., 2016; Liss
et al., 2016), are promising tools to reveal the dynamics and
distribution of effectors on a nanoscale.
INFECTION MODELS
Legionella effectors target fundamental processes, conserved
between protozoa and mammals, resulting in a range of
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 2 January 2018 | Volume 7 | Article 528
Schroeder Functional Genomics of Legionella Effectors
FIGURE 1 | (A) Scheme of the typical architecture of Dot/Icm T4SS effectors. Effectors often show a modular structure consisting of a translocation signal and
localization, target binding and enzymatic activity domains. (B) Reporter systems for determining the translocation and localization of Dot/Icm T4SS effectors.
(1) Fluorophore- or gold particle-conjugated antibodies specific for an effector or an epitope tag are used to detect the effector in host cell lysates by immunoblot or
visualize it by immunofluorescence- or electron microscopy. (2) Cre/loxP recombinase system: After delivery of Cre-effector fusions into recipient cells the recombinase
removes a loxP-flanked disruptor cassette from a gene reporter conferring antibiotic resistance. (3) β-lactamase (TEM-1) assay: Translocation of TEM-1-effector
fusions results in hydrolysis of a green fluorescent β-lactam FRET substrate, separating FRET donor and acceptor, generating a blue fluorescent product.
(4) Calmodulin-dependent adenylate-cyclase (Cya) assay: Upon arrival of a Cya-effector fusion in the host, Cya gets activated by binding calmodulin and turns over
ATP to cyclic AMP, which can be quantified by ELISA. (5) Split-GFP reporter system: Effectors are fused to the small (GFP11) fragment of a split GFP. Upon delivery
into cells expressing the non-fluorescent large (GFP1-10) GFP fragment, spontaneous reassembly of effector-fused GFP11 and GFP1-10 occurs, restoring
fluorescence emission which can be visualized by fixed or live imaging fluorescence microscopy. (6) Halo-tag reporter: After translocation into the host the
Halo-tagged effector can be ligated with versatile fluorophores for detection by conventional, super-resolution- or electron microscopy.
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infection models, which, despite similarities, have each
strengths, and weaknesses. Hartmannella vermiformis,
Naegleria spp. and in particular Acanthamoeba castellanii
and Dictyostelium discoideum are frequently used environmental
hosts (Rowbotham, 1980; Newsome et al., 1985; Fields et al.,
1990; Moffat and Tompkins, 1992; Solomon and Isberg, 2000;
Hoffmann et al., 2014b). Requirements for specific effector
subsets in different protozoa vary and are more stringent than
in macrophages (O’Connor et al., 2011), making protozoa
indispensable to study the evolutionary pressures behind the
acquisition of effectors. To analyze the interaction of Legionella
with macrophages, various mammalian [e.g., U937 (Pearlman
et al., 1988), HL-60 (Marra et al., 1990), THP-1, Raw264.7
(Cirillo et al., 1994), J774 (Husmann and Johnson, 1992), M-HS
(Matsunaga et al., 2001)] and insect [S2 and Kc167 (Dorer et al.,
2006; Sun et al., 2013)] cell lines served as models. Moreover,
non-phagocytic cells [e.g., HEp-2 (Cirillo et al., 1994), A549
(Mousnier et al., 2014), HeLa (Finsel et al., 2013), HEK293
(Losick et al., 2010), CHO (McCusker et al., 1991; Kagan and
Roy, 2002)], with optional ectopic-expression of Fcγ-receptor to
boost the invasion efficiency of Legionella, were employed. To
evaluate the relevance of findings for human disease, differences
in patterns of protein family expansion, e.g., Rab GTPases
(Klöpper et al., 2012), and innate immune signaling, e.g.,
inflammasome activation (Krause and Amer, 2016), between cell
lines, mice and humans need to be considered. Ultimately, results
need validation in primary macrophages and in vivomodels that
approximate the complexity of the human immune system.
Insects such as Drosophila melanogaster (Kubori et al., 2010)
and Galleria mellonella (Harding et al., 2012, 2013b; Aurass et al.,
2013) mount innate immune responses and represent straight-
forward infection models. Tests in mammals, e.g., guinea pigs,
rats, rhesus monkeys, and marmosets, showed that guinea pigs
develop disease similar to humans (Baskerville et al., 1983; Davis
et al., 1983). Mice, with exception of A/J mice, which are defective
in an NAIP5-dependent inflammasome response to flagellin,
are resistant to Legionella (Brieland et al., 1994). Nevertheless,
because of the wealth of engineered mouse strains, infections of
A/J mice with wild-type or non-permissive mice with flagellin-
deficient Legionella have become the predominant in vivomodels
and gave important insight into effector and immune biology
(Brown et al., 2016). In the future, humanized mice (Walsh et al.,
2017) and ex vivo human lung tissue models (Jäger et al., 2014)
will improve our capabilities to define roles of effectors in human
infection.
GENETICS APPROACHES TO DETERMINE
EFFECTOR FUNCTIONS
Legionella is amenable for gene deletion by homologous
recombination (Merriam et al., 1997; Bryan et al., 2011;
O’Connor et al., 2011) and mutagenesis with transposons (Ott,
1994; Pope et al., 1994; Edelstein et al., 1999; O’Connor et al.,
2011). Assays recording intracellular growth by colony counting
or continuously, using fluorescent or bioluminescent strains, are
established (Coers et al., 2007; Tiaden et al., 2013; Schroeder
et al., 2015). Mixed infection competition experiments measuring
performance of a wild type vs. a mutant strain achieved better
resolution of differences in virulence in some cases (Ensminger
et al., 2012; Finsel et al., 2013; Harding et al., 2013b). However,
attenuation of strains lacking single effectors was rarely observed.
Some effectors might be dispensable in a specific host; but
Legionella also achieves resilience by deploying families of
paralogue effectors, which seem functionally redundant (Cazalet
et al., 2004; Chien et al., 2004).
To reduce the complexity of the effector network, O’Connor
and Isberg developed two genetic approaches. Insertional
mutagenesis and depletion (iMAD, Figure 2A) is based on
the combinatorial screening of effector deletion mutants for
intracellular growth in hosts, which are also host factor depleted
(O’Connor et al., 2012; O’Connor and Isberg, 2014). Additive or
compensatory effects of the lack of an effector and a host factor
are monitored and interrogated using computational clustering
and network analysis, grouping effectors with similar profiles and
predicting functional redundancy.
In a second approach five genomic regions were deleted
to create a minimized genome strain lacking 31% of effectors
(O’Connor et al., 2011). This strain grows normally in
macrophages; but is attenuated in protozoa, underlining the
importance of examining several infection models. Subsequently,
the minimized genome strain and intermediates lacking subsets
of the genomic regions proved to be valuable tools to link
Dot/Icm T4SS dependent phenotypes to a chromosomal region
and, through gene-by-gene screening, to individual effectors
(Choy et al., 2012; Arasaki et al., 2017; Kotewicz et al.,
2017). Deletion of additional effectors could generate even
more powerful strains for loss-of-function or gain-of-function
experiments, in which the perturbation of host processes by
individual effectors can be dissected.
HETEROLOGOUS EXPRESSION SYSTEMS
FOR PHENOTYPIC ANALYSIS
Alternatives to investigating effectors during infection rely on
heterologous expression and delivery. These are often technically
and analytically less complex, but do not reflect physiological
concentrations, microenvironment of delivery and the effects
of other effectors. Microinjection of recombinant effectors, e.g.,
SetA (Jank et al., 2012), offers excellent control of concentration
and timing of injection, enabling the characterization of
toxic effectors; however requires protein purification and a
microinjector. Relinquishing the tight control over the delivery,
but reducing technical requirements, microbial microinjection
exploits a Yersinia enterocolitica strain with functional type III
secretion system (T3SS), but lacking effectors (Wölke et al., 2011),
to deliver individual Dot/Icm effectors (Rothmeier et al., 2013).
The suitability of this approach for a wide range of T4SS effectors
still needs confirmation.
Ectopic-expression in mammalian cells remains the
workhorse to assess effector-induced modulation of host
processes and subcellular targeting by co-localization with
organelle markers. Numerous studies exist. Libraries containing
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FIGURE 2 | Genetics and proteomics methods for the functional characterization of Dot/Icm T4SS effectors. (A) Insertional mutagenesis and depletion (iMAD)
disentangles the complex network of effector-host manipulations: (1) Characterization of a Legionella mutant lacking a single effector (E1), which acts through host
protein A, does not result in reduced intracellular growth, because a second effector (E2) induces a redundant process through host protein B. (2) Following the iMAD
strategy, screening of single effector mutants in host cells, which are also depleted for host factors, eliminates redundant pathways, resulting in attenuation of the
strain. (B) Nucleic Acid-Programmable Protein Array (NAPPA) for profiling of host cell targets of effectors: Human genes are printed as array on slides and translated
in vitro. Recombinant Halo-tagged effector is added and after washes reacted with a fluorophore-ligand for the Halo-tag, allowing detection of the human proteins,
which bound and retained the effector on the array. (C) Proteomics approaches for the characterization of effectors: (1) BirA/Bio-tag system: Bio-tagged effector is
translocated into biotin ligase BirA expressing cells leading to biotinlylation of the Bio-tag. After optional cross-linking the bioinylated effector and bound host proteins
are isolated by tandem-affinity purification for interactome analysis by MS. (2) Proximity biotinylation: Translocation of an effector fused to e.g., the peroxidase APEX or
a promiscuous biotin ligase (BioID) results in biotinylation of host proteins in the proximity of the effector, which can be processed as for (1) to identify potential
interactors. (3) Identifying post-translational modifications (PTMs): Infected cells are infused or metabolically-labeled with a chemical substrate analog (CSA) for a
PTM-catalyzing enzyme. Host proteins and effectors, which are modified with the CSA, can be isolated after ligation of an affinity handle such as biotin to the CSA and
characterized by MS. (4) Profiling the enzymatic activities of effectors with activity-based probes (ABPs): Infected cells or lysates are treated with a chemical ABP,
which irreversibly binds to a specific enzyme class and contains or allows addition of an affinity handle. Effectors, which possess such enzymatic activity, react with the
probe, are isolated and identified by MS.
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up to 275 effectors for viral transduction or transfection were
used to screen for effectors, which modulate, e.g., caspase
activation (Zhu et al., 2013), the cytoskeleton (Liu et al., 2017),
translation (Barry et al., 2013), or NF-kB activation (Ge et al.,
2009; Losick et al., 2010).
Saccharomyces cerevisiae is an important tool to study
effectors (Popa et al., 2016). Phenotypic screens identified
Legionella effectors that subvert endosomal trafficking or are
cytotoxic for yeast (Campodonico et al., 2005; Shohdy et al.,
2005). The availability of yeast gene deletion and overexpression
strain collections (Gelperin et al., 2005; Sopko et al., 2006;
Giaever et al., 2014) bears particular potential. These have proven
useful to test enzymatic activities of effectors, e.g., LegS2 or
SidP, in functional complementation assays (Degtyar et al., 2009;
Toulabi et al., 2013) and to profile synergistic and antagonistic
genetic interactions between yeast and effector genes, allowing to
infer affected pathways (Viner et al., 2012). Moreover, screening
of overexpressed host proteins or effectors for suppression of
effector-induced toxicity toward yeast identified host targets,
effectors pairs with antagonistic activities and, so called meta-
effectors, which regulate other effectors (Tan and Luo, 2011; Tan
et al., 2011; Guo et al., 2014; Urbanus et al., 2016).
IDENTIFICATION OF PROTEIN TARGETS
Dissecting the molecular mechanisms underlying effector-
induced phenotypes often requires the identification of host
targets. Yeast two-hybrid screening is a powerful method to
identify protein-protein interactions and was used for several
effectors (Banga et al., 2007; Lomma et al., 2010; Harding
et al., 2013a; Michard et al., 2015). Similarly, pull-down of
interactors from host cell lysates using purified effector or co-
immunoprecipitation (Co-IP) from cells ectopically expressing
an effector bait were frequently used (Machner and Isberg, 2006;
Price et al., 2009; Finsel et al., 2013; Urbanus et al., 2016). In a cell-
free assay system, the Nucleic Acid-Programmable Protein Array
(NAPPA, Figure 2B) (Yu et al., 2015), human bait gene arrays are
translated in vitro, exposed to Halo-tagged effector and bound
effector detected by ligation of a fluorophore to the Halo-tag.
This system, circumventing protein isolation, promises to reveal
a global view of interactors.
Despite their proven value, all above-mentioned in vitro and
heterologous expression methods struggle with the identification
of false-positive and -negative targets, because they do not reflect
the unique proteomic landscape which an effector experiences
when injected at the LCV membrane into a cell that responds to
the infection and is manipulated by hundreds of effectors.
We established a method to determine the interactomes
of effectors during infection (Figure 2C.1) (Mousnier et al.,
2014). Legionella expressing an effector fused to a tandem-
affinity tag including a biotinylation site (Bio-tag), are used to
infect cells expressing Escherichia coli biotin ligase BirA. The
translocated effector is biotinylated, allowing isolation of effector-
host target complexes for analysis by mass spectrometry (MS).
Using this approach, we identified new interactors of PieE and
profiled the infection-relevant interactions of the promiscuous
Rab GTPase-binding effectors SidM and LidA (Mousnier et al.,
2014; So et al., 2016).
Exciting prospects for effector target discovery arise from the
development of proximity-biotinylation systems (Figure 2C.2).
These rely on promiscuous biotinylation of proteins in proximity
of engineered BirA (Roux et al., 2012) or the peroxidase APEX2
(Hung et al., 2016) followed by characterization of biotinylated
targets by MS. Translocation of T3SS effector-APEX2 fusions by
Chlamydia was recently described (Rucks et al., 2017) suggesting
that this could be adopted for T4SS effectors.
PROFILING POST-TRANSLATIONAL
MODIFICATIONS (PTMS) AND ENZYMATIC
ACTIVITIES
Effectors exploit host proteins as receptors (Gaspar andMachner,
2014) and subvert their functions, which is often achieved by
post-translational modification (PTM) (Michard and Doublet,
2015). The discovery of the phosphocholination activity of
AnkX and phosphoribosyl-ubiquitin ligase activity in SdeA
illustrated that careful analysis of protein targets by MS is
key to identify new PTMs (Mukherjee et al., 2011; Bhogaraju
et al., 2016; Qiu et al., 2016). PTM specific antibodies were
used e.g., to study effector-mediated phosphorylation or histone
modifications (Ge et al., 2009; Rolando et al., 2013). This can
be complemented by autoradiography assays using radioactive
substrates, which excel in sensitivity, and are employed to study,
e.g., AMPylation (Neunuebel et al., 2011; Tan and Luo, 2011) or
glycosyltransferase effectors (Jank et al., 2012). Non-radioactive
chemical substrate analogs (CSAs), which can be functionalized
to visualize and isolate modified proteins, were developed for
several PTMs (Grammel et al., 2011; Lu et al., 2012; Fischle and
Schwarzer, 2016). CSAs can also reveal PTMs on effectors, as
demonstrated for the post-translational lipidation of effectors
(Figure 2C.3) (Ivanov et al., 2010; Lin et al., 2015; Schroeder
et al., 2015). CSAs enable profiling of PTMs on proteome level
from cell extracts, living cells or, as shown for SidM-mediated
AMPylation, on NAPPA arrays (Yu et al., 2015), promising global
overviews of PTMs at a coverage similar to the Legionella-shaped
ubiquitinome (Ivanov and Roy, 2013; Bruckert and Abu Kwaik,
2015).
The discovery of new enzymatic activities is challenging as
small molecules, e.g., ATP or lipids, can be substrates and/or
effectors not necessarily target host proteins. Bioinformatic
analysis to identify homologous enzymes and catalytic motifs
is critical to find leads (Watson et al., 2005) for focused
enzymatic assays, as exemplified by LpdA (lipolysis, Schroeder
et al., 2015), SidF (phosphate release, Hsu et al., 2012) or LncP
(nucleotide transport, Dolezal et al., 2012). Biophysical methods,
e.g., differential scanning fluorimetry, allow screening of ligands
(Ciulli, 2013).
For the identification of enzymes-of-interest, e.g., redundant
effectors, in the Legionella proteome activity-based probes
(ABPs) offer a solution (Figure 2C.4). ABPs are typically small
molecules that irreversibly react with a specific enzyme class and
functionalized to allow purification of modified enzymes for MS
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analysis. ABPs are available for many enzymes including the
ubiquitin-conjugation and chromatin-modifying machineries
(Willems et al., 2014; Fischle and Schwarzer, 2016; Hewings et al.,
2017). ABPs will help to disentangle the redundancy problem,
probe for eukaryotic-like enzymes and assign functions in new
Legionella isolates.
SYNTHESIS
Deciphering the functions of thousands of effectors is a
formidable challenge; however new genetics tools and a
rapidly growing number of chemical biology and proteomics
methods provide a well-suited toolbox to reveal fascinating new
mechanisms of host manipulation by Legionella.
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